| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0e9bca1120ab9d2f65b138f53e3eda4d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7ba927d67fa8f640dfd2e02910de83a9 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-54 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6845
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57492 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate |
2019-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_884fed36c21edfa4f1c31680a8bd0ec1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1aab928f357d767680e8dcee48a2de4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_785f0d1573c6e916c7ca9c9c6d7a95b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_282df1bc6a22a3297434db0dcaffa832
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b5829ba0b89b8bfed8a38c67418a588 |
| publicationDate |
2020-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2020080891-A1 |
| titleOfInvention |
Method for predicting recurrence of breast cancer |
| abstract |
Disclosed is a method and a kit for predicting (or diagnosing) a breast cancer prognosis (for example, whether the cancer is recurring) through the analysis of protein-protein interactions from among proteins associated with breast cancer and/or the measurement of expression levels of the proteins associated with breast cancer, or for providing information for the prediction (or diagnosis). In addition, the present invention relates to: a method for predicting (or diagnosing) a breast cancer prognosis or whether breast cancer is recurring or for selecting a patient suitable for HER2 targeted therapy, through HER2 protein expression level; or a method for providing information for the prediction (or diagnosis) or selection. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022029484-A1 |
| priorityDate |
2018-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |